Our EV Research

Diagnosing and monitoring organ-specific diseases (e.g., liver, heart, brain) is challenging due to reliance on invasive biopsies or non-invasive methods lacking precision. Biofluids like blood contain mixed biological signals, making it hard to isolate organ-specific information, hindering accurate diagnosis and treatment tracking.

We aim to develop a novel method to isolate organ-specific EVs from biofluids for biomarker detection. The RNA and protein content of the organ-specific EVs can serve as high quality biomarkers to overcome background noise, enabling accurate, non-invasive disease monitoring and treatment assessment.